Browsing by Author Prat Aparicio, Aleix

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 26 to 45 of 62 < previous   next >
Issue DateTitleAuthor(s)
7-Apr-2021Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancerSchettini, Francesco; Barbao, P; Brasó Maristany, Fara; Galván, Patricia; Martínez, Debora; Paré, Laia; Placido, Sabino De; Prat Aparicio, Aleix; Guedán Carrió, Sònia
Nov-2022Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registriesCortellini, Alessio; Dettorre, Gino M.; Dafni, Urania; Aguilar Company, Juan; Castelo Branco, Luis; Lambertini, Matteo; Gennatas, Spyridon; Angelis, Vasileios; Sita-Lumsden, Ailsa; Rogado, Jacobo; Pedrazzoli, Paolo; Viñal, David; Prat Aparicio, Aleix; Rossi, Maura; Berardi, Rossana; Alonso Gordoa, Teresa; Grisanti, Salvatore; Dimopoulou, Georgia; Queirolo, Paola; Pradervand, Sylvain; Bertuzzi, Alexia; Bower, Mark; Arnold, Dirk; Salazar Soler, Ramón; Tucci, Marco; Harrington, Kevin J.; Mazzoni, Francesca; Mukherjee, Uma; Tsourti, Zoi; Michielin, Olivier; Pommeret, Fanny; Brunet, Joan; Vincenzi, Bruno; Tonini, Giuseppe; Patriarca, Andrea; Biello, Federica; Krengli, Marco; Tabernero Caturla, Josep; Pentheroudakis, George; Gennari, Alessandra; Peters, Solange; Romano, Emanuela; Pinato, David J.
19-Mar-2021Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancerGriguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo
8-Nov-2022Intrinsic Subtypes and Therapeutic Decision-Making in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer with Visceral Crisis: A Case ReportSchettini, Francesco; Seguí, Elia; Conte, Benedetta; Sanfeliu, Esther; González Farré, Blanca; Jares Gerboles, Pedro; Vidal i Sicart, Sergi; Ganau, Sergi; Cebrecos, Isaac; Brasó Maristany, Fara; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix; Vidal Losada, Maria Jesús
28-Mar-2017Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancerFernández Martínez, Aranzazu; Pascual, Tomás; Perrone, Giuseppe; Morales, Serafín; Haba, Juan de la; González Rivera, Milagros; Galván, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucía; Prats de Puig, Miquel; Rojo, Federico; Manso, Luis; Paré, Laia; Alonso, Immaculada; Albanell Mestres, Joan; Vivancos, Ana; González, Antonio; Matito, Judit; González, Sonia; Fernández Ruiz, Pedro Luis; Adamo, Barbara; Muñoz Mateu, Montserrat; Viladot, Margarita; Font, Carme; Aya, Francisco; Vidal Losada, Maria Jesús; Caballero, Rosalía; Carrasco, Eva; Altomare, Vittorio; Tonini, Giuseppe; Prat Aparicio, Aleix; Martín, Miguel
15-May-2012Lunatic Fringe Deficiency Cooperates with the Met/Caveolin Gene Amplicon to Induce Basal-Like Breast CancerXu, Keli; Usary, Jerry; Kousis, Philaretos C.; Prat Aparicio, Aleix; Wang, Dong-Yu; Adams, Jessica R.; Wang, Wei; Loch, Amanda J.; Deng, Tao; Zhao, Wei; Cardiff, Robert D.; Yoon, Keejung; Gaiano, Nicholas; Ling, Vicki; Beyene, Joseph; Zacksenhaus, Eldad; Gridley, Tom; Leong, Wey L.; Guidos, Cynthia; Perou, Charles M.; Egan, Sean E.
1-Sep-2016Modeling anti-IL-6 therapy using breast cancer patient-derived xenograftsMorancho, Beatriz; Zacarías Fluck, Mariano; Esgueva, Antonio; Bernardó Morales, Cristina; Di Cosimo, Serena; Prat Aparicio, Aleix; Cortés, Javier; Arribas, Joaquín V. (Vicente); Rubio, Isabel T.
28-Sep-2022Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancerSchettini, Francesco; Venturini, Sergio; Giuliano, Mario; Lambertini, Matteo; Pinato, David J.; Onesti, Concetta Elisa; De Placido, Pietro; Harbeck, Nadia; Lüftner, Diana; Denys, Hannelore; Van Dam, Peter; Arpino, Grazia; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne; Bartsch, Rupert; Cortés, Javier; Paris, Ida; Martín, Miguel; De Placido, Sabino; Del Mastro, Lucia; Jerusalem, Guy; Curigliano, Giuseppe; Prat Aparicio, Aleix; Generali, Daniele
30-Nov-2022Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53-Mutated Metastatic Colorectal CancerLahoz, Sara; Rodríguez, Adela; Fernández, Laia; Gorría, Teresa; Moreno, Reinaldo; Esposito, Francis; Oliveres, Helena; Albiol, Santiago; Saurí, Tamara; Pesantez, David; Riu Viladoms, Gisela; Cuatrecasas Freixas, Miriam; Jares Gerboles, Pedro; Pedrosa, Leire; Pineda, Estela; Postigo, Antonio; Castells Garangou, Antoni; Prat Aparicio, Aleix; Maurel Santasusana, Joan; Camps, Jordi
Nov-2022Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancerCortellini, Alessio; Aguilar Company, Juan; Salazar Soler, Ramón; Bower, Mark; Sita-Lumsden, Ailsa; Plaja, Andrea; Lee, Alvin J. X.; Bertuzzi, Alexia; Tondini, Carlo; Diamantis, Nikolaos; Martínez, Clara; Prat Aparicio, Aleix; Apthorp, Eleanor; Gennari, Alessandra; Pinato, David J.
8-Jun-2020Nectin-2 Expression on Malignant Plasma Cells Is Associated With Better Response to TIGIT Blockade in Multiple MyelomaLozano Garcia, Ester; Mena Jaramillo, Mari Pau; Díaz Sánchez, Tania; Martin-Antonio, Beatriz; Leon, Sheila; Rodríguez-Lobato, Luis Gerardo; Oliver Caldés, Aina; Cibeira, María Teresa; Bladé, J. (Joan); Prat Aparicio, Aleix; Rosiñol Dachs, Laura; Fernández de Larrea Rodríguez, Carlos José
18-Sep-2019Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trialAdamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; Gonzalez Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix
4-Oct-2012PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular MarkersBastien, Roy R.L.; Rodríguez-Lescure, Álvaro; Ebbert, Mark T.W.; Prat Aparicio, Aleix; Munárriz, Blanca; Rowe, Leslie; Miller, Patricia; Ruiz-Borrego, Manuel; Anderson, Daniel; Lyons, Bradley; Álvarez, Isabel; Dowell, Tracy; Wall, David; Seguí, Miquel A.; Barley, Lee; Boucher, Kenneth M.; Alba, Emilio; Pappas, Lisa; Davis, Carole A.; Aranda, Ignacio; Fauron, Christiane; Stijleman, Inge J.; Palacios, José; Antón, Antonio; Carrasco, Eva; Caballero, Rosalía; Ellis, Matthew J.; Nielsen, Torsten O.; Perou, Charles M.; Astill, Mark; Bernard, Philip S.; Martín, Miguel
25-Sep-2019PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single InstitutionPernas, Sònia; Petit, Anna; Climent, Fina; Paré, Laia; Perez Martin, J.; Ventura, Luz; Bergamino Sirvén, Milana; Galván, Patricia; Falo, Catalina; Morilla, Idoia; Fernandez Ortega, Adela; Stradella, Stradella; Rey, Montse; Garcia Tejedor, Amparo; Gil Gil, Miguel; Prat Aparicio, Aleix
31-Jan-2023Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast CancerTagliamento, Marco; Gennari, Alessandra; Lambertini, Matteo; Salazar Soler, Ramón; Harbeck, Nadia; Mastro, Lucia del; Aguilar Company, Juan; Bower, Mark; Sharkey, Rachel; Pria, Alessia dalla; Plaja, Andrea; Jackson, Amanda; Handford, Jasmine; Sita-Lumsden, Ailsa; Martínez Vila, Clara; Matas, Marta; Miguel Rodríguez, Ana; Vincenzi, Bruno; Tonini, Giuseppe; Bertuzzi, Alexia; Brunet, Joan; Pedrazzoli, Paolo; Avanzo, Francesca d'; Biello, Federica; Sinclair, Alasdair; Lee, Alvin J.X.; Rossi, Sabrina; Rizzo, Gianpiero; Mirallas, Oriol; Pimentel, Isabel; Iglesias, María; Sanchez de Torre, Ana; Guida, Annalisa; Berardi, Rossana; Zambelli, Alberto; Tondini, Carlo; Filetti, Marco; Mazzoni, Francesca; Mukherjee, Uma; Diamantis, Nikolaos; Parisi, Alessandro; Aujayeb, Avinash; Prat Aparicio, Aleix; Libertini, Michela; Grisanti, Salvatore; Rossi, Maura; Zoratto, Federica; Generali, Daniele; Saura, Cristina; Lyman, Gary H.; Kuderer, Nicole M.; Pinato, David J.; Cortellini, Alessio
20-Jan-2020Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockadeBrasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix
1-Dec-2011Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastasesAdamo, Barbara; Deal, Allison M.; Burrows, Emily; Geradts, Joseph; Hamilton, Erika; Blackwell, Kimberly L,; Livasy, Chad; Fritchie, Karen; Prat Aparicio, Aleix; Harrell, J. Chuck; Ewend, Matthew G.; Carey, Lisa A.; Miller, C. Ryan; Anders, Careu K.
30-Apr-2014Phospho-kinase profile of triple negative breast cancer and androgen receptor signalingCuenca López, María D.; Montero, Juan Carlos; Morales, Jorge C.; Prat Aparicio, Aleix; Pandiella, Atanasio; Ocana, Alberto
7-Aug-2014Predicting response and survival in chemotherapy-treated triple-negative breast cancerPrat Aparicio, Aleix; Lluch Hernández, Ana; Albanell Mestres, Joan; Barry, W.T.; Fan, Cheng; Chacón, José Ignacio; Parker, Joel S.; Calvo, L.; Plazaola, A.; Arcusa, Angels; Seguí, Miquel A.; Burgues, O.; Ribelles, N.; Rodríguez-Lescure, Álvaro; Guerrero, A.; Ruiz-Borrego, Manuel; Munárriz, Blanca; López, J.A.; Adamo, Barbara; Cheang, Maggie C. U.; Li Y.; Hu, Z.; Gulley, M.L.; Vidal, Maria José; Pitcher, B.N.; Liu, M.C.; Citron, M.L.; Ellis, Matthew J.; Mardis, Elaine R.; Vickery, T.; Hudis, C.A.; Winer, E.P.; Carey, Lisa A.; Caballero, Rosalía; Carrasco, Eva; Martín, M.; Perou, Charles M.; Alba, Emilio
10-Jun-2011Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype -ACOSOG Z1031Ellis, Matthew J.; Suman, Vera J.; Hoog, Jeremy; Lin, Li; Snider, Jacqueline; Prat Aparicio, Aleix; Parker, Joel S.; Luo, Jingqin; DeSchryver, Katherine; Allred, D.Craig; Esserman, Laura J.; Unzeitig, Gary W.; Margenthaler, Julie; Babiera, Gildy V.; Marcom, P. Kelly; Guenther, Joseph M.; Watson, Mark A.; Leitch, Marylin; Hunt, Kelly; Olson, John A.